Cholesgen Pharmaceutical Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.3M

  • Investors
  • 4

Cholesgen Pharmaceutical General Information

Description

Developer of innovative drugs designed for metabolic diseases and tumor treatment-related diseases. The company integrates the reporter gene screening system based on the target regulation mechanism, the protein small molecule interaction system, and the in vitro drug efficacy test system based on the target function in the research and development of new drugs, and builds an independent research and development platform for biochemical and cell testing to optimize drugs in an all-round way and promote them efficiently In-depth and development of drug research and development, providing medical industry users with innovative drug solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 1077 Zhangheng Road, Pudong New Area
  • Shanghai, 201103
  • China
+86 138
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No. 1077 Zhangheng Road, Pudong New Area
  • Shanghai, 201103
  • China
+86 138

Cholesgen Pharmaceutical Timeline

2022202320242025
Date FoundedFinancing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cholesgen Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 30-May-2023 $14.3M Completed Product Development
1. Seed Round 07-Feb-2021 Completed Startup
To view Cholesgen Pharmaceutical’s complete valuation and funding history, request access »

Cholesgen Pharmaceutical Patents

Cholesgen Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023212817-A1 Steroid compound, and preparation method therefor and application thereof Pending 28-Jan-2022
EP-4471046-A1 Steroid compound, and preparation method therefor and application thereof Pending 28-Jan-2022

Cholesgen Pharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dawu Venture Capital Venture Capital Minority
Gaorong Capital Venture Capital Minority
Wuxi AstraZeneca CICC Venture Capital Partnership Growth/Expansion Minority
Trinity Innovation Fund Venture Capital Minority
To view Cholesgen Pharmaceutical’s complete investors history, request access »

Cholesgen Pharmaceutical FAQs

  • When was Cholesgen Pharmaceutical founded?

    Cholesgen Pharmaceutical was founded in 2021.

  • Where is Cholesgen Pharmaceutical headquartered?

    Cholesgen Pharmaceutical is headquartered in Shanghai, China.

  • What industry is Cholesgen Pharmaceutical in?

    Cholesgen Pharmaceutical’s primary industry is Drug Discovery.

  • Is Cholesgen Pharmaceutical a private or public company?

    Cholesgen Pharmaceutical is a Private company.

  • What is Cholesgen Pharmaceutical’s current revenue?

    The current revenue for Cholesgen Pharmaceutical is .

  • How much funding has Cholesgen Pharmaceutical raised over time?

    Cholesgen Pharmaceutical has raised $14.3M.

  • Who are Cholesgen Pharmaceutical’s investors?

    Dawu Venture Capital, Gaorong Capital, Wuxi AstraZeneca CICC Venture Capital Partnership, and Trinity Innovation Fund have invested in Cholesgen Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »